Research and Development

Showing 15 posts of 9573 posts found.

Unpublished trials ‘violates ethical obligation’ to patients

October 30, 2013 Research and Development, Sales and Marketing BMJ, Goldacre, all trials, trials

A new study published in the BMJ has found almost one in three (29%) of large clinical trials remain unpublished …
baali_muganga

Aesica hires business development manager and director

October 30, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aesica, muganga

Contract development and manufacturing organisation (CDMO) Aesica has appointed Baali Muganga to the role of east coast US business development …
brian_mcnamee_amgen

Amgen promotes two senior executives

October 29, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen

Amgen has promoted two senior executives as Brian McNamee becomes executive vice president and Stuart Tross senior vice president. McNamee …

Strategic planning: don’t just do it, use it

October 28, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, craig, strategic planning

Every year, thousands of pharma employees spend endless hours in meetings discussing, building and presenting brand plans. Countless teams develop …
sanofi pasteur image

Sanofi starts C. diff study

October 28, 2013 Research and Development, Sales and Marketing C diff, Sanofi Pasteur, cdi, clostridium

Sanofi’s vaccines division is beginning a Phase III programme looking at the safety and effectiveness of an investigational treatment for …
dominic_blakemore_shire

Shire hires finance director

October 28, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, dominic blakemore

Dominic Blakemore will join Shire’s Board from January next year as a non-executive director and member of its Audit, Compliance …
astrazeneca image

Phoenix from Charnwood’s ashes

October 25, 2013 Research and Development, Sales and Marketing AstraZeneca, Charnwood, medilink

The shuttering of AstraZeneca’s R&D site at Charnwood in Leicestershire has had a positive effect on the region’s life sciences …
jackson_tai

Banker joins Lilly Board

October 25, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing jackson tai, lilly

Eli Lilly has appointed ex-investment banker Jackson Tai to its Board to serve on the Audit and Finance Committee from …
leo pharma

LEO Pharma to release clinical trial data

October 24, 2013 Research and Development, Sales and Marketing Goldacre, LEO Pharma, all trials, transparency

LEO Pharma has announced that it will start releasing clinical trial data from studies dating back to almost 25 years …
IBM image

IBM tests cancer diagnostic

October 24, 2013 Medical Communications, Research and Development, Sales and Marketing Cancer, Zurich, ibm

IT giant IBM has teamed up with the University Hospital in Zurich to research a new oncology diagnostic test, in …
open access image

Open access splits researchers

October 24, 2013 Medical Communications, Research and Development, Sales and Marketing BMJ, open access, publishing, research

Small medical research charities are worried that the extra costs of open access publishing will have a significant impact on …
dav

Horizon Discovery chairman steps down from Board

October 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing evans, horizon

Research tools firm Horizon Discovery has confirmed that David Evans has stepped down as chairman of its Board. Dr Ian …
capture

HGS founders join IMS Health team

October 23, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HGS, IMS Health, mcfarlane

Healthcare services firm IMS Health has appointed HGS Europe founders Graeme McFarlane and Angela McFarlane (pictured) to its UK team. 
AstraZeneca imge

AZ begins late-stage trial of new cancer drug

October 22, 2013 Research and Development, Sales and Marketing AstraZeneca, Cancer, NSCLC, selumetinib

AstraZeneca has begun a Phase III study for its investigational lung cancer pill selumetinib in patients with a genetic sub-type …
The Gateway to Local Adoption Series

Latest content